Global Sterile Injectables Cdmo Market Size & Outlook
Global sterile injectables cdmo market, 2018-2030 (US$M)
Global sterile injectables cdmo market highlights
- The global sterile injectables cdmo market generated a revenue of USD 3,115.1 million in 2024 and is expected to reach USD 2,945.9 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of -2.7% by 2030.
- In terms of segment, large molecule accounted for a revenue of USD 1,820.8 million in 2024.
- Small Molecule is the most lucrative molecule type segment registering the fastest growth during the forecast period.
- In terms of region, Asia Pacific was the largest revenue generating market in 2024.
- Country-wise, Thailand is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 3,115.1 million |
| Market revenue in 2030 | USD 2,945.9 million |
| Growth rate | -2.7% (CAGR from 2025 to 2030) |
| Largest segment | Large molecule |
| Fastest growing segment | Small Molecule |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
Other key industry trends
- In terms of revenue, the North America accounted for 18.9% of the global sterile injectables cdmo market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Thailand is the fastest growing regional market and is projected to reach USD 125.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sterile Injectables CDMO Market Scope
Sterile Injectables CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global sterile injectables cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sterile injectables cdmo market will help companies and investors design strategic landscapes.
Large molecule was the largest segment with a revenue share of 58.45% in 2024. Horizon Databook has segmented the Global sterile injectables cdmo market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Sterile Injectables CDMO Molecule Type Outlook (Revenue, USD Million, 2018-2030)
- Small Molecule
- Large Molecule
- Global Sterile Injectables CDMO Product Outlook (Revenue, USD Million, 2018-2030)
- Pre-filled Syringes
- Vials and Ampoules
- Specialty Injectables
- Others Product
- Global Sterile Injectables CDMO Service Outlook (Revenue, USD Million, 2018-2030)
- Formulation Development
- Packaging
- Others services
- Analytical and Testing Services
- Method Development and Validation
- Extractable & Leachable Testing
- Others Analytical Services
- Stability Testing
- Drug Substance
- Stability Indicating Method Validation
- Accelerated Stability Testing
- Photostability Testing
- Other Stability Testing Methods
- Manufacturing
- Clinical Trial Manufacturing
- Commercial Manufacturing
- Aseptic Fill-Finish Services
- Storage
- Cold
- Non-cold
- Global Sterile Injectables CDMO Therapeutic Area Outlook (Revenue, USD Million, 2018-2030)
- Oncology
- Cardiovascular Diseases
- Central Nervous System Diseases
- Infectious Disorders
- Musculoskeletal Diseases
- Hormonal Diseases
- Others Therapeutics Area
- Global Sterile Injectables CDMO Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Subcutaneous (SC)
- Intravenous (IV)
- Intramuscular (IM)
- Others route of administration
- Global Sterile Injectables CDMO End Use Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Others End Use
Reasons to subscribe to Global sterile injectables cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global sterile injectables cdmo market databook
-
Our clientele includes a mix of sterile injectables cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global sterile injectables cdmo market , including forecasts for subscribers. This global databook contains high-level insights into Global sterile injectables cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global sterile injectables cdmo market size, by regions, 2018-2030 (US$M)
Top 10 countries: Sterile injectables cdmo market size, 2024 (US$M)
Global sterile injectables cdmo market share, by molecule type, 2024 & 2030 (%, US$M)
Sterile injectables cdmo market: Opportunity assessment by country
Global sterile injectables cdmo market, by region, 2024 (US$M)
| Molecule Type | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1,184.1 | 1,244.3 | 1,321.7 | 1,414.0 | 1,507.4 | 553.7 | 589.8 | 630.6 | 676.5 | 729.0 | 788.5 | 857.0 | 935.8 | 8.2% |
| Europe | 593.9 | 630.2 | 675.8 | 730.0 | 785.7 | 848.9 | 918.8 | 998.3 | 1,088.3 | 1,191.6 | 1,309.7 | 1,446.6 | 526.1 | -12.0% |
| Asia Pacific | 670.7 | 717.7 | 776.3 | 845.7 | 918.1 | 1,000.3 | 1,092.1 | 1,196.7 | 1,315.8 | 1,453.1 | 534.2 | 591.2 | 657.3 | -11.3% |
| Latin America | 233.5 | 246.3 | 262.7 | 282.2 | 302.1 | 324.5 | 349.3 | 377.4 | 409.1 | 445.5 | 486.9 | 534.7 | 590.0 | 9.4% |
| MEA | 121.2 | 126.3 | 133.0 | 140.8 | 148.4 | 156.5 | 165.1 | 174.7 | 184.9 | 196.1 | 208.4 | 221.9 | 236.7 | 6.3% |
| Overall | 2,803.4 | 2,964.8 | 3,169.5 | 3,412.7 | 3,661.7 | 2,883.9 | 3,115.1 | 3,377.7 | 3,674.6 | 4,015.3 | 3,327.7 | 3,651.4 | 2,945.9 | -2.7% |
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
